Assessment of Left Ventricular Hypertrophy in a Trained Athlete: Differential Diagnosis of Physiologic Athlete's Heart From Pathologic Hypertrophy

Progress in Cardiovascular Diseases

Volumn 54, Issue 5, 2012, Pages 387-396

  Pelliccia, Antonio ^a   Maron, Martin S ^b   Maron, Barry J ^c  

^a Italian National Olympic Committee   (Italy)

^b TUFTS MEDICAL CENTER   (United States)

^c MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

Author keywords

Left ventricular hypertrophy; Pathologic hypertrophy; Trained athlete

Indexed keywords

ARTICLE; ATHLETE; BODY COMPOSITION; BODY SIZE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MAGNETIC RESONANCE; DIASTOLE; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; GENDER; GENE MUTATION; HEART ATRIUM HYPERTROPHY; HEART LEFT VENTRICLE FILLING; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE RELAXATION; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; OXYGEN CONSUMPTION; REMISSION; SARCOMERE; SPORT; SUDDEN DEATH; TRAINING; UNITED STATES;

ADAPTATION, PHYSIOLOGICAL; ATHLETES; CARDIOMYOPATHY, HYPERTROPHIC; DIAGNOSIS, DIFFERENTIAL; EXERCISE; FEMALE; HEART VENTRICLES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; PHYSICAL ENDURANCE; PREDICTIVE VALUE OF TESTS; RISK FACTORS; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84857559630     PISSN: 00330620     EISSN: 18731740     Source Type: Journal    
DOI: 10.1016/j.pcad.2012.01.003     Document Type: Article

References (46)

1. Henschen S. Skilanglauf und Skiwettlauf. Eine medizinische Sportstudie,. Mitt Med Klin Upsala (Jena) 1899, 2:15-18.
2. Huston P., Puffer J.C., MacMillan Rodney W. The athletic heart syndrome. N Engl J Med 1985, 315:24-32.
3. Maron B.J., Pelliccia A. The heart of trained athletes: cardiac remodeling and the risks of sports, including sudden death. Circulation 2006, 114:1633-1644.
4. Pluim B.M., Zwinderman A.H., van der Laarse A., et al. The athlete's heart. A meta-analysis of cardiac structure and function. Circulation 1999, 100:336-344.
5. Pelliccia A., Maron B.J. Cardiac adaptations to exercise training. Oxford textbook of sports medicine 1998, 301-320. Oxford University Press. 2nd Ed. M. Harries, C. Williams, W.D. Stanish, L.J. Micheli (Eds.).
6. Morganroth J., Maron B.J., Henry W.L., et al. Comparative left ventricular dimensions in trained athletes. Ann Intern Med 1975, 82:521-524.
7. Ikaheimo M.J., Palatsi I.J., Takkunen J.T. Noninvasive evaluation of the athletic heart: sprinters versus endurance runners. Am J Cardiol 1979, 44:24-30.
8. Longhurst J.C., Kelly A.R., Gonyea W.J., et al. Chronic training with static and dynamic exercise: cardiovascular adaptation, and response to exercise. Circ Res 1981, 48(Suppl I):I172-I178.
9. Spirito P., Pelliccia A., Proschan M., et al. Morphology of the "athlete's heart" assessed by echocardiography in 947 elite athletes representing 27 sports. Am J Cardiol 1994, 74:802-806.
10. Pelliccia A., Spataro A., Caselli G., et al. Absence of left ventricular wall thickening in athletes engaged in intense power training. Am J Cardiol 1993, 72:1048-1054.
11. Pelliccia A., Maron B.J., Culasso F., et al. The athlete's heart in women: echocardiographic characterization of 600 highly trained and elite female athletes. JAMA 1996, 276:211-215.
12. Montgomery H.E., Clarkson P., Dollery C.M., et al. Association of angiotensin-converting enzyme gene I/D polymorphism with change in left ventricular mass in response to physical training. Circulation 1997, 96:741-747.
13. Karjalainen J., Kujala H.M., Stolt A., et al. Angiotensinogen gene M235T polymorphism predicts left ventricular hypertrophy in endurance athletes. J Am Coll Cardiol 1999, 34:494-499.
14. Pelliccia A., Thompson P.D. The genetics of left ventricular remodeling in competitive athletes. J Cardiovasc Med. 2006, 7:267-270.
15. Pelliccia A., Maron B.J., Spataro A., et al. The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. N Engl J Med 1991, 324:295-301.
16. Pelliccia A., Culasso F., Di Paolo F.M., et al. Physiologic left ventricular cavity dilatation in elite athletes. Ann Intern Med 1999, 130:23-31.
17. Fagard R., Aubert A., Lysens R., et al. Noninvasive assessment of seasonal variations in cardiac structure and function in cyclists. Circulation 1983, 67:896-901.
18. Maron B.J., Pelliccia A., Spataro A., et al. Reduction in left ventricular wall thickness after deconditioning in highly trained Olympic athletes. Br Heart J 1993, 69:125-128.
19. Pelliccia A., Maron B.J., De Luca R., et al. Remodeling of left ventricular hypertrophy in elite athletes after long-term deconditioning. Circulation 2002, 105:944-949.
20. Pelliccia A., Maron B.J., DiPaolo F.M., et al. Prevalence and clinical significance of left atrial remodeling in competitive athletes. J Am Coll Cardiol 2005, 46:690-696.
21. Maron B.J., Pelliccia A., Spirito P. Cardiac disease in young trained athletes: insights into methods for distinguishing athlete's heart from structural heart disease, with particular emphasis on hypertrophic cardiomyopathy. Circulation 1995, 91:1596-1601.
22. Sharma S., Maron B.J., Whyte G., et al. Physiologic limits of left ventricular hypertrophy in elite junior athletes: relevance to differential diagnosis of athlete's heart and hypertrophic cardiomyopathy. J Am Coll Cardiol 2002, 40:1431-1436.
23. Klues H.G., Schiffers A., Maron B.J. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. J Am Coll Cardiol 1995, 26:1699-1708.
24. Spirito P., Maron B.J., Bonow R.O., et al. Occurrence and significance of progressive left ventricular wall thinning and relative cavity dilatation in patients with hypertrophic cardiomyopathy. Am J Cardiol 1987, 60:123-129.
25. Maron B.J., Spirito P., Green K.J., et al. Noninvasive assessment of left ventricular diastolic function by pulsed Doppler echocardiography in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1987, 10:733-742.
26. Lewis J.F., Spirito P., Pelliccia A., et al. Usefulness of Doppler echocardiographic assessment of diastolic filling in distinguishing "athlete's heart" from hypertrophic cardiomyopathy. Am J Cardiol 1992, 68:296-300.
27. Derumeaux G., Douillet R., Troniou A., et al. Distinguishing between physiologic hypertrophy in athletes and primary hypertrophic cardiomyopathies. Importance of tissue color Doppler. Arch Mal Coeur Vaiss. 1999, 92:201-210.
28. Vinereanu D., Florescu N., Schulthorpe N., et al. Differentiation between pathologic and physiologic left ventricular hypertrophy by tissue Doppler assessment of long-axis function in patients with hypertrophic cardiomyopathy or systemic hypertension and in athletes. Am J Cardiol 2001, 88:53-58.
29. Rickers C., Wilke N.M., Jerosch-Herold M., et al. Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation 2005, 112:855-861.
30. Maron M.S., Maron B.J., Harrigan C., et al. Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance. J Am Coll Cardiol 2009, 54:220-228.
31. Scharhag J., Schneider G., Urhausen A., et al. Athlete's heart: right and left ventricular mass and function in male endurance athletes and untrained individuals determined by magnetic resonance imaging. J Am Coll Cardiol 2002, 410:1856-1863.
32. Adabag A.S., Maron B.J., Appelbaum E., et al. Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol 2008, 51:1369-1374.
33. Maron B.J., Wolfson J.K., Cirò E., et al. Relation of electrocardiographic abnormalities and patterns of left ventricular hypertrophy identified by 2-dimensional echocardiography in patients with hypertrophic cardiomyopathy. Am J Cardiol 1983, 51:189-194.
34. Pelliccia A., Maron B.J., Culasso F., et al. Clinical significance of abnormal electrocardiographic patterns in trained athletes. Circulation 2000, 102:278-284.
35. Pelliccia A., Di Paolo F.M., Quattrini F.M., et al. Outcomes in athletes with marked ECG repolarization abnormalities. N Engl J Med 2008, 358:152-161.
36. Rawlins J., Carre F., Kervio G., et al. Ethnic differences in physiological cardiac adaptation to intense physical exercise in highly trained female athletes. Circulation 2010, 121:1078-1085.
37. Sharma S., Elliott P.M., Whyte G., et al. Utility of metabolic exercise testing in distinguishing hypertrophic cardiomyopathy from physiologic left ventricular hypertrophy in athletes. J Am Coll Cardiol 2000, 36:864-870.
38. Wang L., Seidman J.G., Seidman C.E. Narrative review: harnessing molecular genetics for the diagnosis and management of hypertrophic cardiomyopathy. Ann Intern Med 2010, 152:513-520.
39. Wordsworth S., Leal J., Blair E., et al. DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model. Eur Heart J 2010, 31:926-935.
40. Bos J.M., Towbin J.A., Ackerman M.J. Diagnostic, prognostic, and therapeutic implications of genetic testing for hypertrophic cardiomyopathy. J Am Coll Cardiol 2009, 54:201-211.
41. Pelliccia A., Kinoshita N., Pisicchio C., et al. Long-term clinical consequences of intense, uninterrupted endurance training in Olympic athletes. J Am Coll Cardiol 2010, 55:1619-1625.
42. Maron B.J., Doerer J.J., Haas T.S., et al. Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006. Circulation 2009, 119:1085-1092.
43. Maron B.J., Zipes D.P. 36th Bethesda Conference: eligibility recommendations for competitive athletes with cardiovascular abnormalities. J Am Coll Cardiol 2005, 45:2-64.
44. Pelliccia A., Fagard R., Bjørnstad H.H., et al. Recommendations for competitive sports participation in athletes with cardiovascular disease. A consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology, and the Working Group of Myocardial and Pericardial diseases of the European Society of Cardiology. Eur Heart J 2005, 26:1422-1445.
45. Maron B.J. Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathy. Circulation 2010, 121:445-456.
46. Maron B.J., Spirito P., Shen W.K., et al. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. JAMA 2007, 298:405-412.